UCB Stock CINNOBER BOAT
Stocks
0NZT
BE0003739530
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 262.00 EUR | 0.00% |
|
0.00% | - |
| 06-25 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| 06-22 | UBS Trims UCB's PT, Affirms Buy Rating | MT |
| Market Cap | 50.16B 57.29B 46.31B 43.24B 81.4B 5,416B 83.25B 557B 215B 2,672B 215B 210B 9,277B | P/E 2026 * |
28.3x | P/E 2027 * | 22.1x |
|---|---|---|---|---|---|
| Enterprise Value | 49.24B 56.23B 45.45B 42.44B 79.9B 5,316B 81.72B 547B 211B 2,623B 211B 207B 9,106B | EV / Sales 2026 * |
5.77x | EV / Sales 2027 * | 4.91x |
| Free-Float |
61.59% | Yield 2026 * |
0.56% | Yield 2027 * | 0.57% |
Last Transcript: UCB
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2014-12-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 2020-06-30 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2011-12-31 | |
| Director/Board Member | 67 | 2014-12-31 | |
| Director/Board Member | 56 | 2014-04-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 57.29B | |
| -0.71% | +1.72% | +19.74% | -12.51% | 64.28B | |
| -3.94% | +39.10% | +39.10% | +39.10% | 43.45B | |
| -0.56% | +1.65% | -51.04% | -58.77% | 38.02B | |
| -0.25% | +9.84% | +72.47% | -23.96% | 31.98B | |
| +2.52% | +17.60% | +160.00% | -40.96% | 27.66B | |
| +0.02% | +10.08% | +68.75% | +84.61% | 22.91B | |
| -0.56% | +5.64% | +2.91% | +174.96% | 17.74B | |
| -0.13% | -0.94% | +60.31% | +119.58% | 16.45B | |
| +2.40% | +7.17% | +70.33% | +327.60% | 14.1B | |
| Average | -0.13% | +6.92% | +49.17% | +67.74% | 30.73B | |
| Weighted average by Cap. | -0.48% | +6.00% | +41.14% | +30.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.53B 9.75B 7.88B 7.36B 13.85B 921B 14.16B 94.8B 36.6B 455B 36.6B 35.8B 1,578B | 9.63B 10.99B 8.89B 8.3B 15.62B 1,039B 15.98B 107B 41.28B 513B 41.29B 40.38B 1,780B |
| Net income | 1.75B 1.99B 1.61B 1.51B 2.83B 189B 2.9B 19.4B 7.49B 93.03B 7.49B 7.33B 323B | 2.29B 2.61B 2.11B 1.97B 3.71B 247B 3.79B 25.4B 9.81B 122B 9.81B 9.59B 423B |
| Net Debt | -925M -1.06B -854M -797M -1.5B -99.88B -1.54B -10.28B -3.97B -49.28B -3.97B -3.88B -171B | -2.93B -3.35B -2.71B -2.53B -4.76B -317B -4.87B -32.58B -12.58B -156B -12.58B -12.3B -542B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- UCB Stock
- 0NZT Stock
Select your edition
All financial news and data tailored to specific country editions
